mtps9579a
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 15, 2019 (NCT04092582)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05129423 | Phase 2 | Dec 15, 2021 | Genentech, Roche |
| NCT04092582 | Phase 2 | Oct 15, 2019 | Genentech, Roche |
Showing 2 of 2 trials
Page 1 / 1